Agilon Health
AGL
85.70
+2.30
+2.76%
Agilon Health
US · AGL
#3034 by market cap
Listed 2021
85.70
+2.30
+2.76%
Live - 5344 symbols - heartbeat 546s ago
· 2026-10-08 08:02
Pre-market
85.90
+0.23%
After-hours
85.70
0.00%
- Market cap
- 1.44B
- P/E (TTM)i
- -6.03
- P/Bi
- 6.32
- EPSi
- -23.75
- Div yieldi
- 0.00%
- 52W posi
- 62%
Reader sentiment
Are you bullish or bearish on AGL?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 12 analysts
Hold
Avg price target
117.56 +37.2%
Price target rangecurrent 85.70
Low85.00
Avg117.56
High146.00
Buy 25%
Hold 67%
Sell 8%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | Bernstein | -- | BUY | 125.00 |
| 2026-09-28 | Truist Financial | -- | HOLD | -- |
| 2026-09-15 | Bernstein | -- | BUY | 125.00 |
| 2026-08-24 | Truist Financial | -- | HOLD | -- |
| 2026-08-24 | J.P. Morgan | -- | SELL | 85.00 |
| 2026-08-11 | Citi | -- | HOLD | 115.00 |
| 2026-08-10 | Wells Fargo | -- | BUY | 146.00 |
| 2026-08-10 | Citi | -- | HOLD | 115.00 |
| 2026-08-07 | TD Cowen | -- | HOLD | 95.00 |
| 2026-08-06 | StoneX | -- | BUY | 140.00 |
| 2026-08-06 | Truist Financial | -- | HOLD | 112.00 |
| 2026-08-06 | Baird | -- | HOLD | 116.00 |
| 2026-08-06 | Evercore | -- | HOLD | 125.00 |
| 2026-08-06 | Needham | -- | HOLD | -- |
| 2026-08-06 | Citi | -- | SELL | 105.00 |
| 2026-08-06 | Barclays | -- | HOLD | 111.00 |
| 2026-08-05 | William Blair | -- | HOLD | -- |
| 2026-07-23 | Citi | -- | SELL | 105.00 |
| 2026-07-15 | Wells Fargo | -- | BUY | 141.00 |
| 2026-07-13 | Wells Fargo | -- | BUY | 141.00 |
| 2026-05-27 | Bernstein | -- | HOLD | 86.00 |
| 2026-05-21 | Benchmark Co. | -- | BUY | 95.00 |
| 2026-05-15 | Bernstein | -- | HOLD | 86.00 |
| 2026-05-15 | Citi | -- | HOLD | 80.00 |
| 2026-05-11 | TD Cowen | -- | HOLD | 55.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Hold
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
4 1
■ Upgrades■ Downgrades
- 4 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Bernstein moved from Hold to Buy on 2026-09-15.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-15 | Bernstein | HOLD → BUY | 125.00 |
| 2026-08-10 | Citi | SELL → HOLD | 115.00 |
| 2026-08-06 | Barclays | SELL → HOLD | 111.00 |
| 2026-07-23 | Citi | HOLD → SELL | 105.00 |
| 2026-05-07 | Deutsche Bank | HOLD → BUY | 49.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | After close | ±22.24% | -19.49% (in line) |
| 2026/Q1 | 2026-05-06 | After close | ±19.92% | +117.81% (beat) |
| 2025/Q4 | 2026-02-25 | After close | -- | +18.92% |
| 2025/Q3 | 2025-11-04 | After close | ±51.78% | +4.05% (in line) |
| 2025/Q2 | 2025-08-05 | After close | ±31.81% | +1.12% (in line) |
| 2025/Q1 | 2025-05-06 | After close | ±24.66% | -23.99% (in line) |
| 2024/Q4 | 2025-02-25 | After close | ±24.43% | -7.44% (in line) |
| 2024/Q3 | 2024-11-07 | After close | ±21.79% | -34.05% (beat) |
| 2024/Q2 | 2024-08-06 | After close | ±22.67% | -9.32% (in line) |
| 2024/Q1 | 2024-05-07 | After close | ±18.47% | +4.22% (in line) |
| 2023/Q4 | 2024-02-27 | After close | ±27.08% | -1.85% (in line) |
| 2023/Q3 | 2023-11-02 | After close | ±18.50% | -13.20% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:02:55 · For reference only, not investment advice and not tailored to your situation.